Review Article
Print
Review Article
Vitamin D as a drug: new therapeutic approaches
expand article infoMohd Alaraj, Fahaad S. Alenazi§, Dania Hassan|, Ashfaque Hossain
‡ Middle East University, Amman, Jordan
§ University of Hail, Hail, Saudi Arabia
| Department of Medical Microbiology and Immunology RAK Medical and Health Sciences University, Ras Al Khaimah, United Arab Emirates
¶ Central Research Laboratory RAK Medical and Health Sciences University, Ras Al Khaimah, United Arab Emirates
Open Access

Abstract

Vitamin D is one of the essential vitamins and has recently been demonstrated to be much more important for the appropriate functioning of the human body and well-being than initially believed. Although vitamin D is mainly known for its link with bone fractures and bone diseases, recent studies revealed that vitamin D and its analogues have revealed many pharmacological actions covering the regulation of cell growth, inhibition of inflammation, and improvement of neuromuscular function and immune function. Moreover, vitamin D and its analogues are reported to have role in different types of cancers, skin diseases, diabetes mellitus and infections caused by different bacterial and viral pathogens including SARS-CoV-2. The goal of this study is to evaluate the scientific literature on therapeutic uses of vitamin D and its analogues against different diseases and health condition. Special attention has been given to COVID-19 infection, cancer, skin diseases, and diabetes. The molecular mechanisms involved are also explored.

Keywords

calcidiol, calcitriol, vitamin D3, SARS-CoV-2

Introduction

Vitamin D comprises a collection of fat-soluble secosteroid organic compounds that have anti-rickets properties. The key D vitamins are vitamin D2 (ergocalciferol) and D3 (cholecalciferol) (Raposo et al. 2017; Melguizo-Rodríguez et al. 2021), in which the name “calciferol” comes from the words “calcium” and “ferro.” This name is intended to illustrate the fact that this vitamin is necessary for maintaining healthy bones and calcium levels. Currently, vitamin D deficiency is believed to be one of the most persistent health complications. It seriously disturbs the body’s homeostasis and increases the threat of certain cancers, type 2 diabetes, and cardiovascular diseases (Melguizo-Rodríguez et al. 2021). It is obvious that the administration of vitamin D to a person suffering from hypovitaminosis D compensates for this deficiency and removes the symptoms of the disease. But in the case of people who are not suffering from deficiency, vitamin D administration may exert certain pharmacological effects that can be used for therapeutic purposes, such as preventing infection and alleviating the effects of COVID-19 (Ali 2020; Meltzer et al. 2020).

Occurrence

It is estimated that 90–95% of the vitamin D required is generated through skin synthesis, while diet is the secondary source of this vitamin in the human body (Aydın et al. 2019). The cholecalciferol form of vitamin D is found in animal products, while ergocalciferol is found in plant-based products. Vitamin D2 is produced from the provitamin ergosterol, which is found in yeast (Hnokaew and Yammuen-Art SYA 2021), milk, butter, and especially fish oil. Under the influence of ultraviolet radiation, the provitamin dehydrocholesterol is formed in the skin.

Several years ago, it was found that actual vitamin D3 is calcitriol, while cholecalciferol is a provitamin that is converted to calcitriol in the kidneys (Whiting et al. 2021). Alfacalcide is derived from vitamin D3 as a very strong metabolite that is used in conditions when the body is unable to convert cholecalciferol into calcifediol due to kidney dysfunction. Thus, it is used for patients with liver and kidney injury who have symptoms of hypovitaminosis D (Galassi et al. 2021).

Pharmacokinetics

Absorption; vitamin D3 is a lipid-soluble molecule that is absorbed into the lacteals in the gastrointestinal tract through chylomicrons. It is then transported via the lymphatic system and subsequently into the blood stream (Charoenngam et al. 2021). Distribution; the bound phase of circulating vitamin D3 is around 60%, and the free phase is quickly eliminated into the muscle, and adipose tissue-due to the action of lipoprotein lipase (Haddad et al. 1993). Metabolism; metabolism of this vitamin takes place in the liver to (25(OH)D) (Haddad et al. 1993). Next, 25(OH)D is metabolized by 25-hydroxyvitamin D-1α-hydroxylase (CYP27B1) in the kidneys into the active metabolite 1,25-dihydroxyvitamin D (1,25(OH)2D) (Holick 2007). Excretion; vitamin D3 is mainly excreted through the bile into the feces. As part of the absorbed vitamin D is diluted in the adipose tissue, obese individuals have high risk of vitamin D deficiency (Lespessailles and Toumi 2017; Wortsman 2000).

Pharmacodynamics

The role of the vitamin D receptor in the functioning of vitamin D3 in the body

Vitamin D receptor (VDR) mediates the hormonal function of calcitriol in several physiological processes in the human body (Uberti 2016; Shang and Sun 2017). VDR is a representative of the steroid-thyroid – retinoid superfamily of nuclear transcription factors, which are directly activated via small lipophilic molecules that are responsible for the regulation of gene transcription (Saksa et al. 2015). This receptor is expressed in more than 38 types of human cells and in almost all organs, including the hair follicles, muscles, bone marrow, ducts of the gastrointestinal tract, and the brain (Guo et al. 2013; Bakke and Sun 2018; Lee et al. 2018).

Calcitriol interacts with the receptors via two pathways: the classical genomic associated pathway, where calcitriol interacts with the nuclear VDR, and the non-genomic pathway, where this vitamin interacts with the membrane VDR (Venter et al. 2001). It has been proven that 1,25-dihydroxycholecalciferol can regulate about 3–5% of genes in the human genome by activating VDRs (Chen et al. 2016). Genes that are controlled by VDRs are responsible for regulating the metabolism of calcium and its absorption from the gut, as well as cell proliferation and differentiation, the hair growth cycle, and function of the immune system, among others (Guo et al. 2013). One of the target genes for VDR is CYP24A1, which controls the level of calcitriol (Chen et al. 2016).

Role in the body

Vitamin D is vital for the appropriate functioning of the whole body, particularly through its effects on metabolic processes (Wisniewska and Szypowska 2021). This vitamin is an essential and basic factor that determines proper calcium management in the body (together with calcitonin and para-thyroid hormones, which are also secreted in the thyroid gland) (Prentice et al. 2013). Vitamin D principally augments the absorption of calcium and phosphate from the gastrointestinal tract and prevents their excretion in the urine, thus elevating the blood-calcium concentration and enhancing the deposition of calcium phosphate in the bones. Therefore, proper bone mineralization depends on the presence of adequate levels of these vitamins, and without them, calcium does not accumulate in the bones (Prentice et al. 2013). Vitamin D also has important roles in many extra-skeletal targets (Fig. 1), including the immune system, central nervous system and cardiovascular system (Bouillon 2017; Bouillon et al. 2019).

Figure 1. 

Extra-skeletal importance of vitamin D in different body systems.

Potential therapeutic uses

SARS-CoV-2 virus infection

Vitamin D3 has been suggested as a possible adjunct therapy for COVID-19 due to the in vitro observations of antiviral and protective effects against respiratory tract infections (including rhinovirus and respiratory syncytial virus infections), as well as its immunomodulation effects (Ling et al. 2020; Tan et al. 2020). It has been suggested that vitamin D3 can decrease the intensity of viral infection by inducing antimicrobial peptides and enhancing cellular immunity. This occurs by decreasing the concentration of pro-inflammatory cytokines and increasing the concentration of anti-inflammatory cytokines (Wang et al. 2021a). It is also generally accepted that vitamin D3 may prevent complications of COVID-19 by regulating the renin-angiotensin system (RAS) (Figs 2, 3), innate and adaptive cellular immunity, and the integrity of physical barriers, as well as supporting the control of comorbidities, such as hypertension and diabetes (Annweiler et al. 2020).

Figure 2. 

Potential therapeutic role of vitamin D for COVID-19.

Figure 3. 

Mechanism of action of vitamin D supplementations in treatment of COVID-19.

A number of clinical studies have examined or are currently exploring the relationship of vitamin D3 with SARS-CoV-2 infection. A retrospective cohort study showed that people infected with the SARS-CoV-2 virus had more than two-times lower serum concentrations of calcidiol on average than those in the control group (11.1 ng/ml and 24.6 ng/ml, respectively, P = 0.004) (D’Avolio et al. 2020). Another observational study examined data from 20 different European countries and showed a negative correlation between the mean serum concentration of calcidiol and the morbidity and mortality caused by COVID-19 (Ilie et al. 2020). This result is also supported by retrospective observational studies conducted on a group of 130 people aged 76 ± 13 years, half of which were the control group. The authors postulate that vitamin D3 deficiency in patients was associated with a more severe course of COVID-19, longer duration of the disease, and the risk of death in the elderly (Sulli et al. 2021). All of these studies show the effectiveness of vitamin D3 supplementation as an adjunctive therapy in the treatment of COVID-19. However, further studies on much larger, representative groups of people are necessary.

Vitamin D is reported to have a protective effect against SARS-CoV-2 infection, which prompted its inclusion in both preventive and treatment regimens for COVID-19. Serum vitamin D concentration is reported to serve as predictor of SARS-CoV-2 infection, which is independent of age, sex, race and attitude (Ilie et al. 2020). In comparison to placebo, a single high dose of vitamin D is reported to have an immediate beneficial effect on hospitalized COVID-19 patients in terms of shortening the duration of hospitalization and reducing the need for mechanical ventilation (Jaun et al. 2022)

Although some progresses have been made in understanding the molecular basis of action of vitamin D, the total picture is not clear. However, enhanced expression of antimicrobial proteins, defensin and cathelicidin which are reported to play important role in the infection outcome process of various bacterial and viral agent(Kearns et al. 2015; Fiske et al. 2019; Tomaszewska et al. 2022) is speculated to have an important role in vitamin D induced protective functions in SARS = CoV-2 infection. Additionally, vitamin D is also speculated to have a protective effect in alleviating COVID-19 infection especially in patients with severe symptoms and lung damage as it is reported to have a similar role in enhancing lung immunity in respiratory diseases (Hansdottir and Monick. 2011).

SARS-CoV-2 infection is often leads to neurological symptoms such as loss of smell and taste, dizziness and confusion as a result of damages to the neurons caused by the virus. Vitamin D exerts neuroprotective effect by regulating the production of neurophilins, which are key factors modulating survival, differentiation and proliferation of neurons. Studies have shown that vitamin D promotes the migration and proliferation of oligodendrocytes, enhancing the remyelination of damaged neurons in animal models (Gomez-Pinedo et al. 2020), suggesting a possible mechanism through which it can alleviate neurological symptoms. Taken together, these findings highlight the importance of vitamin D as an adjunct therapeutic agent against infection caused by SARS-CoV-2.

Cancer diseases

Increasing evidence suggests that vitamin D and its derivatives exhibit antitumor effects in mice (Aslam et al. 2021; Li et al. 2021) and humans (Wang et al. 2021b) and decrease the proliferation of cancer cells derived from several tissues (Hassan et al. 2022). Moreover, the expression of VDRs rises with malignant transformation and declines with advanced tumour growth, and activation of these receptors stimulates more than 60 genes, leading to pro-differentiating, anti-proliferative, and anti-metastatic effects on cells (Kim et al. 2012). It is also accepted that vitamin D and its analogues can suppress cancer cell growth by modifying cell-cycle progression and can induce apoptosis in various cancer cells (Schneider et al. 2022). Furthermore, vitamin D can enhance TNFa (Chen et al. 2021) and can act as a pro-oxidant in cancer cells (McConnell et al. 2018).

Nonetheless, the key adverse effects of vitamin D – hypercalcemia and hypercalciuria – restrict its utilization in cancer therapy (Rizzoli 2021). Therefore, more than 3000 vitamin D analogues have been synthesized, and some of them display fewer toxic effects and more effectiveness than vitamin D (Gu et al. 2021). However, large multicentre randomized controlled trials are urgently needed to explore which vitamin D analogues are effective for cancer, either alone or in combination with other anticancer drugs.

Skin diseases

Vitamin D can increase the production of several antimicrobial peptides as well as the effects of cytokine and T helper type 2 cells. Thus, using this vitamin could decrease the risk of skin infection (Umar et al. 2018). Likewise, vitamin D and its analogues are already utilized in the treatment of atopic dermatitis, psoriasis, vitiligo, acne, and rosacea. But the effectiveness of these agents varies from 4 to 53% (Kechichian and Ezzedine 2018) and this is ascribed to the enormously variable nature of psoriasis and its diverse presentations in patients (Ben-Shabat et al. 2005). Additionally, many of these agents have serious adverse effects, such as hypercalciuria and hypercalcemia (Ben-Shabat et al. 2005). However, it has been revealed that calcipotriol is a safe and very effective topical drug for the treatment of hyperproliferative skin diseases, such as psoriasis (McCormack 2011).

Although the mechanism of action of vitamin D and its analogues is not fully understood, it is known that this vitamin can augment keratinocyte differentiation and either activate or inhibit keratinocyte growth depending on the dose (Umar et al. 2018). Similarly, vitamin D can also elevate the production of platelet-derived growth factor (PDGF), thus supporting wound healing, as well as TNFa, which supports keratinocyte differentiation (Geilen et al. 1997). Decreased synthesis of IL-1a, IL-6, and chemokine ligand 5 resulting from vitamin D decrease inflammation in epidermal keratinocytes (Fujita et al. 2007).

Diabetes mellitus

Both type 1 and type 2 diabetes can be prevented or treated with vitamin D and its analogues. This results from normalizing the function of the immune system, promoting B-cell survival and function, facilitating insulin secretion and glucose uptake, and controlling insulin-receptor gene expression (Sintov et al. 2014; Abdel-Rehim et al. 2019). This vitamin has been demonstrated to normalize the action of B cells and can affect the muscle and fat cells. Furthermore, it can elevate insulin action by decreasing insulin resistance as well as inhibiting inflammation, which is usually associated with type 2 diabetes (Sintov et al. 2014).

Conclusion

A growing body of clinical, experimental, and epidemiological studies suggests that vitamin D and its analogues may have therapeutic potential, particularly for the prevention and treatment of COVID-19 infection, various cancers, diabetes, and some skin diseases. Nevertheless, further long-term randomized controlled trials on vitamin D and its analogues are required to better understand their efficiency in the prevention and therapy for diseases, their adverse effects, and their molecular mechanisms of actions.

Acknowledgements

The authors are grateful to the Middle East University, Amman, Jordan, for the financial support to cover the publication fee of this research article.

References

  • Abdel-Rehim WM, El-Tahan RA, El-Tarawy MA, Shehata RR, Kamel MA (2019) The possible antidiabetic effects of vitamin D receptors agonist in rat model of type 2 diabetes. Molecular and cellular biochemistry 450(1): 105–112. https://doi.org/10.1007/s11010-018-3377-x
  • Annweiler C, Beaudenon M, Gautier J, Simon R, Dubée V, Gonsard J, Parot-Schinkel E (2020) COvid-19 and high-dose VITamin D supplementation TRIAL in high-risk older patients (COVIT-TRIAL): study protocol for a randomized controlled trial. Trials 21(1): 1–10. https://doi.org/10.1186/s13063-020-04928-5
  • Aslam A, Ahmad J, Baghdadi MA, Idris S, Almaimani R, Alsaegh A, Alhadrami M, Refaat B (2021) Chemopreventive effects of vitamin D3 and its analogue, paricalcitol, in combination with 5-fluorouracil against colorectal cancer: The role of calcium signalling molecules. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1867(3): е166040. https://doi.org/10.1016/j.bbadis.2020.166040
  • Aydın CG, Dinçel YM, Arıkan Y, Taş SK, Deniz S (2019) The effects of indoor and outdoor sports participation and seasonal changes on vitamin D levels in athletes. SAGE Open Medicine 7: 2050312119837480. https://doi.org/10.1177/2050312119837480
  • Bakke D, Sun J (2018) Ancient nuclear receptor VDR with new functions: microbiome and inflammation. Inflammatory bowel diseases 24(6): 1149–1154. https://doi.org/10.1093/ibd/izy092
  • Ben-Shabat S, Benisty R, Wormser U, Sintov AC (2005) Vitamin D3–based conjugates for topical treatment of psoriasis: synthesis, antiproliferative activity, and cutaneous penetration studies. Pharmaceutical research 22(1): 50–57. https://doi.org/10.1007/s11095-004-9008-0
  • Bouillon R, Marcocci C, Carmeliet G, Bikle D, White JH, Dawson-Hughes B, Lips P, Munns CF, Lazaretti-Castro M, Giustina A, Bilezikian J (2019) Skeletal and extraskeletal actions of vitamin D: current evidence and outstanding questions. Endocrine reviews 40(4): 1109–1151. https://doi.org/10.1210/er.2018-00126
  • Charoenngam N, Kalajian TA, Shirvani A, Yoon GH, Desai S, McCarthy A, Apovian CM, Holick MF (2021) A pilot-randomized, double-blind crossover trial to evaluate the pharmacokinetics of orally administered 25-hydroxyvitamin D3 and vitamin D3 in healthy adults with differing BMI and in adults with intestinal malabsorption. The American journal of clinical nutrition 114(3): 1189–1199. https://doi.org/10.1093/ajcn/nqab123
  • Chen PZ, Li M, Duan XH, Jia JY, Li JQ, Chu RA, Yu C, Han JH, Wang H (2016) Pharmacokinetics and effects of demographic factors on blood 25 (OH) D3 levels after a single orally administered high dose of vitamin D3. Acta Pharmacologica Sinica 37(11): 1509–1515. https://doi.org/10.1038/aps.2016.82
  • Chen Y, Hou J, Xiao Z, Zhao Y, Du F, Wu X, Li M, Zhang L, Cho CH, Wen Q, Hu W (2021) The Role of Vitamin D in Gastrointestinal Diseases: Inflammation, Gastric Cancer, and Colorectal Cancer. Current medicinal chemistry 29(22): 3836–3856. https://doi.org/10.2174/0929867328666211111163304
  • D’Avolio A, Avataneo V, Manca A, Cusato J, De Nicolò A, Lucchini R, Keller F, Cantù M (2020) 25-Hydroxyvitamin D concentrations are lower in patients with positive PCR for SARS-CoV-2. Nutrients 12(5): 1359. https://doi.org/10.3390/nu12051359
  • Fiske CT, Blackman A, Maruri F, Rebeiro PF, Huaman M, Kator J, Scott Algood HM, Sterling TR (2019) Increased Vitamin D Receptor Expression from Macrophages after Stimulation with M. tuberculosis Among Persons Who Have Recovered from Extrapulmonary Tuberculosis. BMC Infectious Diseases 19: e366. https://doi.org/10.1186/s12879-019-3958-7
  • Galassi A, Ciceri P, Porata G, Iatrino R, Boni Brivio G, Fasulo E, Magagnoli L, Stucchi A, Frittoli M, Cara A, Cozzolino M (2021) Current treatment options for secondary hyperparathyroidism in patients with stage 3 to 4 chronic kidney disease and vitamin D deficiency. Expert Opinion on Drug Safety 20(11): 1333–1349. https://doi.org/10.1080/14740338.2021.1931117
  • Geilen CC, Bektas M, Wieder T, Kodelja V, Goerdt S, Orfanos CE (1997) 1α, 25-Dihydroxyvitamin D3 induces sphingomyelin hydrolysis in HaCaT cells via tumor necrosis factor α. Journal of Biological Chemistry 272(14): 8997–9001. https://doi.org/10.1074/jbc.272.14.8997
  • Gomez-Pinedo U, Cuevas JA, Benito-Martín MS, Moreno-Jiménez L, Esteban-Garcia N, Torre-Fuentes L, Matias-Guiu JA, Pytel V, Montero P, Matias-Guiu J (2020) Vitamin D Increases Remyelination by Promoting Oligodendrocyte Lineage Differentiation. Brain and Behavior 10(1): e01498. https://doi.org/10.1002/brb3.1498
  • Guo C, Rosoha E, Lowry MB, Borregaard N, Gombart AF (2013) Curcumin induces human cathelicidin antimicrobial peptide gene expression through a vitamin D receptor-independent pathway. The Journal of Nutritional Biochemistry 24(5): 754–759. https://doi.org/10.1016/j.jnutbio.2012.04.002
  • Gu J, Rodriguez K, Yang S, Ociepa M, Wilke H, Abrishami A, Joergensen L, Skak-Nielsen T, Chen J (2021) Convergent Total Synthesis of (+)-Calcipotriol: A Scalable, Modular Approach to Vitamin D Analogs. ChemRxiv. Cambridge: Cambridge Open Engage.
  • Haddad JG, Matsuoka LY, Hollis BW, Hu YZ, Wortsman J (1993) Human plasma transport of vitamin D after its endogenous synthesis. The Journal of Clinical Investigation 91(6): 2552–2555. https://doi.org/10.1172/JCI116492.
  • Hassan AN, Toma T, Ciftci H, Biswas T, Tahara Y, Radwan MO, Tateishi H, Fujita M, Otsuka M (2022) A vitamin D C/D ring-derived compound with cytotoxicity. Medicinal Chemistry Research 31: 1120–1125. https://doi.org/10.1007/s00044-021-02842-2
  • Hnokaew P, Yammuen-Art SYA (2021) Vitamin D2 production and in vitro ruminal degradation of UV-B irradiated vitamin D enriched yeast in Thai native cattle. Veterinary Integrative Sciences 19(3): 537–556. https://doi.org/10.12982/VIS.2021.042
  • Ilie PC, Stefanescu S, Smith L (2020) The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality. Aging clinical and experimental research 32(7): 1195–1198. https://doi.org/10.1007/s40520-020-01570-8
  • Jaun F, Boesing M, Lüthi-Corridori G, Abig K, Makhdoomi A, Bloch N, Lins C, Raess A, Grillmayr V, Haas P, Schuetz P, Gabutti L, Muser J, Leuppi-Taegtmeyer AB, Giezendanner S, Brändle M, Leuppi JD (2022) High-dose vitamin D substitution in patients with COVID-19: study protocol for a randomized, double-blind, placebo-controlled, multi-center study – VitCov Trial. Trials 23(1): 1–11. https://doi.org/10.1186/s13063-022-06016-2
  • Kim SH, Chen G, King AN, Jeon CK, Christensen PJ, Zhao L, Simpson RU, Thomas DG, Giordano TJ, Brenner DE, Hollis B (2012) Characterization of vitamin D receptor (VDR) in lung adenocarcinoma. Lung cancer 77(2): 265–271. https://doi.org/10.1016/j.lungcan.2012.04.010
  • Lee SM, Meyer MB, Benkusky NA, O’Brien CA, Pike JW (2018) The impact of VDR expression and regulation in vivo. The Journal of steroid biochemistry and molecular biology 177: 36–45. https://doi.org/10.1016/j.jsbmb.2017.06.002
  • Li J, Luco AL, Camirand A, St-Arnaud R, Kremer R (2021) Vitamin D regulates CXCL12/CXCR4 and epithelial-to-mesenchymal transition in a model of breast cancer metastasis to lung. Endocrinology 162(7): bqab049. https://doi.org/10.1210/endocr/bqab049
  • Ling SF, Broad E, Murphy R, Pappachan JM, Pardesi-Newton S, Kong MF, Jude EB (2020) High-dose cholecalciferol booster therapy is associated with a reduced risk of mortality in patients with COVID-19: a cross-sectional multi-centre observational study. Nutrients 12(12): 3799. https://doi.org/10.3390/nu12123799
  • McConnell DD, McGreevy JW, Williams MN, Litofsky NS (2018) Do anti-oxidants vitamin D3, melatonin, and alpha-lipoic acid have synergistic effects with temozolomide on cultured glioblastoma cells? Medicines 5(2): 58. https://doi.org/10.3390/medicines5020058
  • Melguizo-Rodríguez L, Costela-Ruiz VJ, García-Recio E, Luna-Bertos D, Ruiz C, Illescas-Montes R (2021) Role of Vitamin d in the Metabolic Syndrome. Nutrients 13(3): 830. https://doi.org/10.3390/nu13030830
  • Melguizo-Rodríguez L, Costela-Ruiz VJ, García-Recio E, Luna-Bertos D, Ruiz C, Illescas-Montes R (2020) Association of vitamin D status and other clinical characteristics with COVID-19 test results. JAMA network open 13(9): e2019722. https://doi.org/10.3390/nu13030830
  • Prentice RL, Pettinger MB, Jackson RD, Wactawski-Wende J, Lacroix AZ, Anderson GL, Chlebowski RT, Manson JE, Van Horn L, Vitolins MZ, Datta M (2013) Health risks and benefits from calcium and vitamin D supplementation: Women’s Health Initiative clinical trial and cohort study. Osteoporosis International 24(2): 567–580. https://doi.org/10.1007/s00198-012-2224-2
  • Raposo L, Martins S, Ferreira D, Guimarães JT, Santos AC (2017) Vitamin D, parathyroid hormone and metabolic syndrome-the PORMETS study. BMC endocrine disorders 17(1): 1–10. https://doi.org/10.1186/s12902-017-0221-3
  • Saksa N, Neme A, Ryynänen J, Uusitupa M, de Mello VD, Voutilainen S, Nurmi T, Virtanen JK, Tuomainen TP, Carlberg C (2015) Dissecting high from low responders in a vitamin D3 intervention study. The Journal of Steroid Biochemistry and Molecular Biology 148: 275–282. https://doi.org/10.1016/j.jsbmb.2014.11.012
  • Schneider J, Jeon YW, Suh YJ, Lim ST (2022) Effects of Ruxolitinib and Calcitriol Combination Treatment on Various Molecular Subtypes of Breast Cancer. International Journal of Molecular Sciences 23(5): 2535. https://doi.org/10.3390/ijms23052535
  • Sulli A, Gotelli E, Casabella A, Paolino S, Pizzorni C, Alessandri E, Grosso M, Ferone D, Smith V, Cutolo M (2021) Vitamin D and lung outcomes in elderly COVID-19 patients. Nutrients 13(3): 717. https://doi.org/10.1016/j.drudis.2014.06.008
  • Tan CW, Ho LP, Kalimuddin S, Cherng BP, Teh YE, Thien SY, Wong HM, Tern PJ, Chandran M, Chay JW, Nagarajan C (2020) Cohort study to evaluate the effect of vitamin D, magnesium, and vitamin B12 in combination on progression to severe outcomes in older patients with coronavirus (COVID-19). Nutrition 79: е111017. https://doi.org/10.1016/j.nut.2020.111017
  • Tomaszewska A, Rustecka A, Lipińska-Opałka A, Piprek RP, Kloc M, Kalicki B, Kubiak JZ (2022) The Role of Vitamin D in COVID-19 and the Impact of Pandemic Restrictions on Vitamin D Blood Content. Frontiers in pharmacology 13: е836738. https://doi.org/10.3389/fphar.2022.836738
  • Uberti F, Bardelli C, Morsanuto V, Ghirlanda S, Molinari C (2016) Role of vitamin D 3 combined to alginates in preventing acid and oxidative injury in cultured gastric epithelial cells. BMC gastroenterology, 16(1): 1–13. https://doi.org/10.1186/s12876-016-0543-z
  • Umar M, Sastry KS, Al Ali F, Al-Khulaifi M, Wang E, Chouchane AI (2018) Vitamin D and the pathophysiology of inflammatory skin diseases. Skin pharmacology and physiology 31(2): 74–86. https://doi.org/10.1159/000485132
  • Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, Smith HO, Yandell M, Evans CA, Holt RA, Gocayne JD (2001) The sequence of the human genome. science 291(5507): 1304–1351. https://doi.org/10.1126/science.1058040
  • Wang R, DeGruttola V, Lei Q, Mayer KH, Redline S, Hazra A, Mora S, Willett WC, Ganmaa D, Manson JE (2021a) The vitamin D for COVID-19 (VIVID) trial: A pragmatic cluster-randomized design. Contemporary clinical trials 100: е106176. https://doi.org/10.1016/j.cct.2020.106176
  • Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF (2000) Decreased bioavailability of vitamin D in obesity. The American journal of clinical nutrition 72(3): 690–693. https://doi.org/10.1093/ajcn/72.3.690
login to comment